PRINCETON, N.J., Dec. 1, 2005 (PRIMEZONE) -- The Bull Market Report (http://www.bullmarket.com), a long-term growth and income-generating focused online investment newsletter, announced today that it has provided subscribers with a look at medical device makers Stryker (NYSE:SYK), Zimmer Holdings (NYSE:ZMH), and Biomet (Nasdaq:BMET).
All paid and trial subscribers to The Bull Market Report can now receive immediate access to The Bull Market Report's exclusive daily reports. As a trial or paid subscriber, you'll also gain access to our latest investment moves. Start your 14-day free trial today:
https://www.bullmarket.com/subscribe/?refer=BMR64
In its report, The Bull Market Report wrote: "Delayed surgeries because of hurricanes in the Gulf of Mexico, pricing pressure in some markets, and disappointing quarterly results at Smith & Nephew (NYSE:SNN) have all played a part in pulling stocks in the sector down to 52-week lows -- levels they're not far from right now. Outside of pricing, these issues are short-term problems. Some erosion of pricing power is no small matter, of course, but these firms are moving into new areas."
In its coverage, The Bull Market Report looked at the following topics, among many others:
-- What new area is Zimmer Holdings moving into that looks promising?
-- What challenges do orthopedic device makers face going forward?
-- Will these firms be able to keep their lofty margins?
-- Despite these challenges, why does the group look compelling at
current levels?
About The Bull Market Report:
Launched in 1997, The Bull Market Report has a strong track record of creating wealth for its subscribers by providing sound, long-term investing advice. The Bull Market Report's Recommended List includes over 50 companies across all major industries, including Financials, Healthcare, Energy, Technology, and Retail, among others. As a testament to the durability of its value-focused and fundamentally sound recommendations in both up and down markets, The Bull Market Report is one of the oldest continuously published investment newsletters online. Start your 14-day free trial today:
https://www.bullmarket.com/subscribe/?refer=BMR64
Subscribers also receive access to The Bull Market Report's special bonus reports, "Search Sector Outlook," "Biotech Sector Outlook," and "Understanding the Value of Insider Trading Data."
Note: This release was published by Indie Research, LLC (CRD #131926). Indie Research, LLC and the Bull Market editorial staff are not registered investment advisors, broker/dealers, or research analysts/organizations.